CervoMed Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
CRVO$1.43+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. EXHIBITS
| Exhibit No. | Description | Method of Filing |
| 31.1 | Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) | Filed herewith. |
| 31.2 | Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) | Filed herewith. |
| 32.1 | Certification of Principal Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) | Furnished herewith. |
| 32.2 | Certification of Principal Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) | Furnished herewith. |
| 101.INS* | Inline XBRL Instance Document | Filed herewith. |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | Filed herewith. |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | Filed herewith. |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | Filed herewith. |
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | Filed herewith. |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | Filed herewith. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101) | Filed herewith. |
- XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CervoMed Inc. | ||
| Date: May [15], 2026 | By: | /s/ John Alam |
|---|---|---|
| John Alam | ||
| President and Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| Date: May [15], 2026 | By: | /s/ William Elder |
| William Elder | ||
| Chief Financial Officer and General Counsel | ||
| (Principal Financial Officer) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.